Literature DB >> 26464740

From lymphocytic interstitial pneumonia to MALT lymphoma of lung: a case report with a 5-year diagnostic dilemma.

Wei Wu1, Jing Zhou1, Li-Gai Di1, Hui Chen1.   

Abstract

Lymphocytic interstitial pneumonia (LIP) and mucosa-associated lymphoid tissue (MALT) lymphoma of lung are all uncommon disorders of respiratory system. MALT lymphoma of lung is a distinct and unique subtype of marginal zone B-cell non-Hodgkin's lymphoma (NHL) characterized by malignant cells arising from extranodal sites. They are characteristic of exuberant lymphoid infiltration in pathological tissue. Therefore, in some cases, they are too similar in clinical manifestation, chest imaging and pathology to make differential diagnosis. Here, we report a 43-year-old woman who underwent a tough process for the final diagnosis. From this case, we could get a well understanding of difference between LIP and MALT lymphoma of lung.

Entities:  

Keywords:  Lymphocytic interstitial pneumonia; diagnosis; lymphocytes; mucosa-associated lymphoid tissue lymphoma

Mesh:

Year:  2015        PMID: 26464740      PMCID: PMC4583972     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Radiological appearances of lymphomas arising from mucosa-associated lymphoid tissue (MALT) in the lung.

Authors:  P G O'Donnell; S A Jackson; K T Tung; B Hassan; B Wilkins; G M Mead
Journal:  Clin Radiol       Date:  1998-04       Impact factor: 2.350

2.  What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites?

Authors:  N L Harris; P G Isaacson
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

3.  Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

Authors:  Hongtao Ye; Hongxiang Liu; Ayoma Attygalle; Andrew C Wotherspoon; Andrew G Nicholson; Frederic Charlotte; Veronique Leblond; Paul Speight; John Goodlad; Anne Lavergne-Slove; Jose Ignacio Martin-Subero; Reiner Siebert; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

4.  Pulmonary interstitial disease in Ig deficiency.

Authors:  Valentin Popa; Thomas V Colby; Stanley B Reich
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

5.  Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis.

Authors:  J E Arends; F J Bot; I A Gisbertz; H C Schouten
Journal:  Histopathology       Date:  1999-09       Impact factor: 5.087

Review 6.  CT-histologic correlation of the ATS/ERS 2002 classification of idiopathic interstitial pneumonias.

Authors:  Conrad Wittram; Eugene J Mark; Theresa C McLoud
Journal:  Radiographics       Date:  2003 Sep-Oct       Impact factor: 5.333

7.  Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.

Authors:  L R Zukerberg; L J Medeiros; J A Ferry; N L Harris
Journal:  Am J Clin Pathol       Date:  1993-10       Impact factor: 2.493

8.  CD43 expression in B cell lymphoma.

Authors:  J Treasure; A Lane; D B Jones; D H Wright
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

9.  Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases.

Authors:  M N Koss; L Hochholzer; J M Langloss; W D Wehunt; A A Lazarus
Journal:  Pathology       Date:  1987-04       Impact factor: 5.306

10.  Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis.

Authors:  W D Travis; C H Fox; K O Devaney; L M Weiss; T J O'Leary; F P Ognibene; A F Suffredini; M J Rosen; M B Cohen; J Shelhamer
Journal:  Hum Pathol       Date:  1992-05       Impact factor: 3.466

View more
  1 in total

1.  A case report of lymphoid intestitial pneumonia in common variable immunodeficiency: Oligoclonal expansion of effector lymphocytes with preferential cytomegalovirus-specific immune response and lymphoproliferative disease promotion.

Authors:  Przemyslaw Zdziarski; Andrzej Gamian; Grzegorz Dworacki
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.